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Sexual distress and quality of life 
among women with bipolar disorder
Thea Sørensen1,2, A. Giraldi2,3 and M. Vinberg1,3* 
Abstract 
Background: Information on the association between bipolar disorder (BD), sexual satisfaction, sexual function, 
sexual distress and quality of life (QoL) is sparse. This study aims, in women with BD, to (i) investigate sexual dysfunc-
tion, sexual distress, general sexual satisfaction and QoL; (ii) explore whether sexual distress was related to affective 
symptoms and (iii) investigate whether QoL was associated with sexual distress. The study is a questionnaire survey in 
an outpatient cohort of women with BD using: Changes in Sexual Functioning Questionnaire, Female Sexual Distress 
Scale, Altman Self-Rating Mania Scale (ASRM), Major Depression Inventory (MDI) and The World Health Organisation 
Quality of Life-Brief.
Results: In total, 61 women (age range 19–63, mean 33.7 years) were recruited. Overall, 54% reported sexual distress 
(n = 33) and 39% were not satisfied with their sexual life (n = 24). Women with BD were significantly more sexually 
distressed in comparison with Danish women from the background population but they did not have a higher preva-
lence of impaired sexual function. Better sexual function was positively associated with ASRM scores while MDI scores 
were associated with more distress. Finally, the group of non-sexually distressed women with BD reported higher QoL 
scores compared with the sexually distressed group.
Conclusions: Women with BD exhibited a high prevalence of sexual distress and their sexual function seemed asso-
ciated with their actual mood symptoms and perception of QoL.
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Background
Sexual dysfunction is defined as an impaired sexual func-
tion that causes distress. The definition has changed sev-
eral times over the course of time but a division into four 
categories overall has remained: desire/interest, arousal, 
orgasm and pain disorders (Basson et  al. 2000, 2004, 
2010; McCabe et al. 2016). Sexual dysfunction is caused 
by biological, psychological and social interactions and 
factors with negative influence on human well-being. 
Additionally, the risk of sexual dysfunction is increased 
by factors such as socio-economic status (Christensen 
et  al. 2011a), psychiatric disorders (Brotto et  al. 2011), 
partner status and the length of relationship (Hayes et al. 
2008; Eplov et  al. 2007), menopause (Ornat et  al. 2013) 
and the side effects of psychotropic treatment (Bergh and 
Giraldi 2014; Serretti and Chiesa 2011a; Zemishlany and 
Weizman 2008). A Danish study (n =  4415) concluded 
that mental health problems and poor self-rated health 
problems were strongly associated with female sexual 
dysfunction (Christensen et al. 2011b).
Information on the association between bipolar disor-
der, quality of life, sexual satisfaction, sexual function and 
distress is sparse. It is well known that depression and 
antidepressants affect sexual function negatively (Clayton 
et  al. 2014), but only a few studies include women with 
BD. Besides, the studies have small study populations 
and different questionnaires, none of which include sex-
ual distress (Dell’Osso et al. 2009; Ghadirian et al. 1992; 
Grover et  al. 2014). In an Italian study (Dell’Osso et  al. 
2009) comparing 142 patients (60 with BD and 82 with 
unipolar depression) with 101 healthy controls, patients 
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with BD reported more sexual dysfunction compared to 
healthy control persons. Patients with BD had increased 
sexual desire in comparison with patients with unipolar 
disorder in the Italian study. Also, the presence of peri-
ods characterised by frequent sexual partners was signif-
icantly associated with the feeling that life is not worth 
living and sexual dysfunction was associated with life-
time suicide attempts. Finally, a Dutch study in the gen-
eral population of the Netherlands showed an association 
between BD and sexual dissatisfaction (Vanwesenbeeck 
et al. 2014).
Episodes of depression or mania can be trigged by 
stress. Patients with BD are probably more easily dis-
tressed, and therefore, sexual distress could be a potential 
trigger for depression and/or mania. The possible rela-
tionship between sexual distress and affective symptoms 
in patients with BD has not been evaluated previously. 
Further, quality of life (QoL), the general well-being and 
observed life satisfaction in many aspects—for example, 
physical and psychological health, education, employ-
ment, wealth, finance, environment, social relations and 
sexual function—are important aspects of QoL. Patients 
with affective disorders have a lower score of QoL com-
pared to the general population (Nørholm 2008; Yatham 
et  al. 2004; Nørholm and Bech 2001). When measuring 
QoL, according to World Health Organisation, sexual sat-
isfaction is included as part of the total score (WHOQOL 
Group 1998). To improve treatment and QoL clinically 
in patients with BD, it is thus important to also focus on 
and include sexual function. The aim of the present study 
was, in a cohort of women with BD, to (i) investigate sex-
ual function, sexual distress, general sexual satisfaction 
and QoL; (ii) explore whether sexual distress was related 
to affective symptoms and (iii) investigate whether QoL 
was associated to sexual distress.
Methods
Study design
Women with BD were recruited to the questionnaire 
survey from the waiting room at the Copenhagen Affec-
tive Disorder Clinic, Psychiatric Centre Copenhagen. 
The included sample was derived from 1 March to 9 May 
2015 from patients attending a region-wide secondary 
service for patients with primary bipolar disorders. The 
patients received written and oral information about the 
project before deciding whether to participate. Further, at 
the time the questionnaire was answered and diagnosis 
confirmed, medication was assessed from the patients’ 
medical records.
The self-assessment questionnaire included param-
eters, among others, previously shown to affect sexual 
function: basic demographic information (age, education, 
civil status, sexual orientation, length of relationship, 
employment and information about children) and life-
style (alcohol, smoking and weight). The other part of the 
questionnaire included is described below.
Participants
The inclusion criteria were as follows: being women with 
a clinical diagnosis of BD, aged 18–70 years, reading and 
understanding Danish and willing to participate in the 
study. Participants were included in analyses independ-
ent of their answers, sexual preference, civil status, age 
and sexual activity. They were excluded from analysis 
when not diagnosed with BD according to their elec-
tronic hospital records.
The control group consisted of a group of Danish 
women from a previous study conducted by our group 
(Giraldi et  al. 2015) describing sexual function. In sum-
mary, these data were collected from a cross-sectional 
study of a large, broadly sampled, non-clinical population 
cohort of Danish women (573 women participated). They 
were drawn randomly from the Danish Central National 
Register and invited to participate by letter. The Danish 
women were included if they were sexually active with a 
partner within the 4 weeks prior (n = 429). As the con-
trol group had a significant higher mean age, we con-
ducted an age-matched analysis between women with 
BD and a subsample of age-matched women from the 
control group (n = 122).
Sexual function
The Female Sexual Function Index (FSFI) and Female 
Sexual Distress Scale (FSDS) were used to describe sexual 
function among the Danish women in the background 
population. They were categorised as having female 
sexual dysfunction (FSD) when FSFI score was  ≤26.55 
(impaired sexual function) and FSDS score ≥15 (Giraldi 
et al. 2015). In the present cohort, female sexual dysfunc-
tion was defined as a CSFQ-14 score ≤41 (impaired sex-
ual function) and FSDS score ≥15 (distress).
Questionnaires
WHOQoL‑BREF, Quality of Life measure
Quality of life was assessed using an abbreviated ver-
sion of the World Health Organisation Quality of Life 
Assessment brief version, WHOQoL-BREF (WHOQOL 
Group 1998), Danish version. The WHOQoL-BREF is a 
26-item questionnaire developed from the original 100-
item questionnaire the WHOQoL-100. The WHOQoL-
BREF covers four different subscales (WHOQoL Group 
1998): physical health (energy and fatigue, pain and 
discomfort, sleep and rest), psychological health (bod-
ily image and appearance, negative feelings, positive 
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feelings, self-esteem, thinking, learning, memory and 
concentration), social relationships (personal relation-
ships, social support and sexual activity) and environ-
ment (e.g. financial resources, freedom, physical safety 
and security, health and social care). Besides, one global 
item scores overall quality of life (overall QoL) and one 
global item scores general health. Each individual item 
of the WHOQoL-BREF is scored from one to five on a 
response scale. The scores are then transformed linearly 
to a 0–100 scale except items one and two, overall QoL 
and general health which are displayed in raw scores 1–5 
(Noerholm et  al. 2004). Higher scores indicate better 
QoL. The internal consistency of the Danish WHOQoL-
BREF was, in a pilot study, found to be psychometrically 
valid (Nørholm and Bech 2001). Finally, satisfaction with 
sexual life was assessed from item 21 (WHOQoL-BREF, 
“How satisfied are you with your sexual life?”) and cat-
egorised as unsatisfied when answered as “very unsatis-
fied” or “unsatisfied”.
Altman Self‑Rating Mania Scale (ASRM)
Manic symptom scale scores were assessed by a short 
5-item questionnaire that covered the symptoms of posi-
tive mood, self-confidence, sleep patterns, speech pat-
terns/amount and motor activity. Each item is scored 
from 0 to 4 and depends on how the participants 
described their symptoms over the past week. Scores 
above five are indicative of mania or hypomania with the 
severity of symptoms increasing with higher scores (Alt-
man et al. 1997).
Major (ICD‑10) Depression Inventory (MDI)
Depression was measured by a 10-item questionnaire 
developed to measure DSM-IV and ICD-10 diagnoses 
of moderate to severe depression by self-reported symp-
toms during the past 2 weeks. The first three items cover 
the core symptoms of depression according to ICD-10 
(depressed mood, lack of interest and lack of energy) 
while the other items cover the accompanying symptoms 
(lack of self-confidence, self-blame or guilt, thoughts of 
death or suicide, difficulty thinking and concentrating, 
agitation or inhibition, sleep disturbances and appe-
tite and weight change). Each item has a possible score 
between 0 and 5 (0 = at no time, 5 = all the time). Items 
8 and 10 were divided into two sub-items and only the 
highest scores of these items were included in the analy-
sis. The theoretical score was 50 with a range from 0 (no 
depression) to 50 (major depression) and a higher score 
indicating the severity of depression. Cut-off scores ≥26 
indicate moderate to severe depression. The internal 
and external validity were found to be psychometrically 
valid in two Danish studies (Bech et al. 2001; Olsen et al. 
2003).
Changes in Sexual Functioning Questionnaire‑14 (CSFQ‑14)
Sexual function was assessed by a questionnaire contain-
ing 14 questions with a total cut-off score ≤41 indicat-
ing impaired sexual function. Each item is scored in a 
5-point scale that refers either to frequency (“never” to 
“every day”) or to satisfaction (“none” to “great”). The 
first item scores overall pleasure with present sexual life 
and the other items cover five subscales (sexual pleasure, 
sexual desire/frequencies, sexual desire/interest, arousal/
excitement and orgasm), and two items (10 + 14) about 
loss of arousal and painful orgasm (de Boer et  al. 2014; 
Keller et al. 2006). CSFQ-14 has been validated to assess 
sexual dysfunction among patients taking antipsychotics 
and also covers all stages of sexual functioning compared 
to other questionnaires (de Boer et al. 2014). A score ≤41 
is seen as an impaired sexual function and thus indicates 
sexual dysfunction (Keller et al. 2006).
Female Sexual Distress Scale (FSDS)
Sexual distress was assessed by a 12-item questionnaire 
that covers the intensity and frequency of sexual distress 
the past 30 days. Each item scores from 0 to 4 (0 = never 
and 4  =  always). A cut-off score  ≥15 indicates sexual 
distress. FSDS has been validated in studies, including a 
pilot study with 60 healthy women and 18 women with 
different kinds of sexual dysfunction. It was concluded 
that the questionnaire is able to distinguish between 
those with and without sexual dysfunction and the study 
showed moderate positive correlation to general mental 
distress, and thus seems to be a good estimate of sexual 
distress (Derogatis et al. 2002).
Ethical statement
Written informed consent was obtained from all partici-
pants. The study was approved by the Danish Data Pro-
tection Agency, Journal Number: 03568 and ID-Number: 
RHP-2015-004.
Statistical analysis
All analyses were conducted using the Statistical Pack-
age for Social Sciences (version 22.0). Spearman’s cor-
relation coefficients were used to test the associations 
between the variables (data measured from an ordinal 
scale). Chi square tests were used to compare variables 
within two groups and prevalence values between two 
groups. The study population (women patients with 
BD), Danish women from the background population 
as well as the age-matched controls were, separately, 
dichotomised into two groups: sexually distressed or 
not sexually distressed. An independent t test was 
used to compare mean scores and standard deviations. 
To investigate whether MDI scores or WHOQoL sub-
scales were predictive of sexual distress, binary logistic 
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regression analyses including age and depression score 
according to MDI and the five WHOQoL subscales 
(general health, physical health, psychological health, 
social relationships and environment), were conducted, 
respectively.
Finally, we compared information on sexual function 
among women with BD with data from women from the 
Danish background population and age-matched con-
trols from this group, respectively.
Results
Study characteristics
In total, 85 women were asked to participate; 14 did not 
answer the questionnaires (response rate 83.5%), eight 
were not diagnosed with BD and a further two did not 
fully complete the questionnaires, thus leaving 61 partici-
pants (72% included). As seen from Table 1, the partici-
pants were characterised by being young, single without 
children, heterosexual, well-educated and unemployed. 
The majority were non-smokers and overweight to obese 
(BMI > 25).
Almost all were prescribed medication, especially 
mood stabilisers (mean number of medication: 2.2), and 
half were in remission. Women with BD and BMI  >  25 
were not prescribed more types of medication (mean 2.1) 
than those with BMI < 25 (mean 2.3). Four women (6.6%) 
did take lithium in combination with benzodiazepines 
and three of them reported sexual dysfunction.
Most women were sexually active (87%). All the sexu-
ally inactive (n  =  8) women reported impaired sexual 
function but three of them did not report sexual distress. 
Half of the sexually inactive women with BD were older 
than 50 years, single or in a relationship for many years 
(25 or 31  years). Four women with BD were older than 
50 years old and they all reported impaired sexual func-
tion but we did not find a correlation between a lower 
CSFQ-14 score and higher age (r = −0.17, P = 0.20).
Impaired sexual function, sexual distress and general 
sexual satisfaction—prevalence, mean scores 
and correlation to affective symptoms
As seen from Table  2, 21 (34.4%) women with BD 
reported impaired sexual function (CSFQ-14 score ≤41). 
However, six patients were not distressed by this result-
ing in 15 (24.6%) out of 21 patients having a sexual dys-
function (impaired sexual function combined with sexual 
distress). Thirty-three (54.1%) women with BD had sexual 
distress. More than one-third was unsatisfied (answering 
“very unsatisfied” or “unsatisfied” to the question “How 
satisfied are you with your sexual life?”) with their sex-
ual life. The study population had a mean score ± SD of 
Table 1 Demographic data and  background characteris-
tics of women with BD, N = 61, standard deviation I brack-
ets
Altman Self-Rating Mania Scale (ASRM) number of patients with current 
hypomania/manias defined as a score >5. Major Depression Inventory (MDI) 
number of patients with current depression defined as a score ≥26 (moderate/
severe). Remission defined as ASRM scores <5 and MDI score <26
WHOQoL-BREF World Health Organisation Quality of Life-BREF
a Five patients were prescribed selective serotonin reuptake inhibitors (SSRI) 
and serotonin and noradrenaline reuptake inhibitors (SNRI), one patient a 
combination of SNRI and Agomelatin and two patients Agomelatin
b Five patients with depression also reported ASRM scores with a mean score 
ASRM = 10
Age (range 19–63 years) 33.7 (10.0)
Education
 No training 7 (12%)
 Higher education 38 (62%)
 Other 16 (26%)
Employed 19 (31%)
Sexual orientation
 Heterosexual 50 (82%)
 Homosexual/bisexual 11 (18%)
Civil status
 Single 28 (46%)
 Married 7 (11%)
 Cohabiting with partner 11 (18%)
 In a relationship, but live apart 15 (25%)
Children 23 (38%)
Children living at home 18 (30%)
Current smoker 21 (34%)
Menopause 5 (8%)
Body mass index (BMI = kg/m2); mean ± SD 26 (6)
 BMI < 18.5 (underweight) 2 (3%)
 BMI 18.5–25 (normal weight) 28 (46%)
 BMI > 25 (overweight to obesity) 31 (51%)
Medication
 Antidepressants 8a (13%)
 Antipsychotics 35 (57%)
 Sleeping pills/benzodiazepines 24 (39%)
 Mood stabilisers/lithium 50 (82%)
 No medication 4 (7%)
Affective symptoms
 ASRM 10 (16%)
 MDI 20b (33%)
 In remission 31 (51%)
WHOQoL-BREF; mean ± SD
 Overall QoL 3.3 (0.9)
 General health 2.0 (1.1)
 Physical health 62.7 (17.5)
 Psychological health 26.9 (19.8)
 Social relationships 58.7 (22.4)
 Environment 62.6 (14.6)
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CSFQ-14 score of 45.2 ±  10.4; FSDS score 15.9 ±  11.3; 
ASRM scores 3.7 ± 3.8 and MDI score 19.7 ± 12.1.
Using Spearman’s correlation, sexual function (CSFQ-
14 score) was positively correlated with ASRM scores 
(r = 0.26, P = 0.04) but not with MDI scores (r = −0.02, 
P = 0.88). However, sexual distress was positively corre-
lated with MDI scores (r = 0.33, P = 0.01) but not with 
ASRM scores (r = 0.11, P = 0.42). Thus overall, general 
sexual satisfaction did not correlate with affective symp-
tom scale scores (ASRM scores r = 0.13, P = 0.32; MDI 
scores r = −0.21, P = 0.10).
Comparison with the background population
As seen from Table 2, women with BD did not have a sig-
nificantly higher prevalence of impaired sexual function 
or sexual dysfunction compared to Danish women from 
the background population but they were significantly 
more often sexually distressed (P = 0.001, n = 429), also 
when using an age-matched subsample from the back-
ground population (P  =  0.04, n  =  122). Age-matched 
controls (n = 122) also had a lower BMI than the study 
population but almost equal percentage of women in 
menopause (8% vs. 7%).
Quality of life
Sexual function was positively associated with QoL and 
social relationships. Better sexual function and less sex-
ual distress was associated with a higher degree of sat-
isfaction with sexual life (r = 0.51, P = 0.00, r = −0.32, 
P =  0.01) and higher QoL score (Table  3), respectively. 
Finally, QoL scores, including the four subscales of 
WHOQoL, were negatively correlated with MDI scores.
In post hoc analyses dividing the women with BD 
into two groups—not sexually distressed and sexually 
distressed—the sexually distressed group had signifi-
cantly lower scores for psychological health and a trend 
towards higher depression score according to MDI 
(P  =  0.07) (Table  4). In further analyses exploring the 
influence of MDI scores on the level of reported sexual 
distress, a multiple linear regression analysis adjusted 
for age and self-reported depressive symptoms accord-
ing to MDI was conducted and showed that the MDI 
Table 2 Sexual dysfunction and sexual distress
Prevalence and comparison between women with bipolar disorder and women from the Danish background population including age-matched control persons
Data are prevalence (%). Data from the background population is from a Danish study (Giraldi et al. 2015). FSFI =  Female Sexual Function Index (background 
population, impaired sexual function cut-off ≤26.55). CSFQ-14 = Changes of Sexual Functioning Questionnaire (study population, impaired sexual function cut-off 
score ≤41). FSDS = Female Sexual Distress Scale (score ≥15 = sexual distress). Sexual dysfunction (FSFI cut-off ≤26.55 or CSFQ cut-off score ≤41 combined with FSDS 
score ≥15)
a Answering “very unsatisfied” or “unsatisfied” to “How satisfied are you with your sexual life?” In background population: “bad” or “very bad” to “How do you appraise 
your sexual life?”
Study population 
(n = 61)
Background population 
(n = 429)
P (study and  
background)
Age-matched 
(n = 122)
P (study and  
age-matched)
Sexual dysfunction 15 (24.6) 72 (16.8) 0.19 25 (20.5) 0.53
Impaired sexual function (FSFI 
or CSFQ-14)
21 (34.4) 140 (32.6) 0.89 45 (36.9) 0.74
Sexual distress (FSDS) 33 (54.1) 115 (26.8) 0.001 46 (37.7) 0.04
Unsatisfied with sexual  lifea 24 (39.3) 86 (20.0) 0.001 – –
Table 3 Spearman’s correlations between  WHOQoL-BREF scores, affective symptoms and  sexual function and  distress 
in a cohort of women with bipolar disorder
R and P values (in brackets)
WHOQoL-BREF World Health Organisation Quality of Life-BREF, ASRM Altman Self-Rating Mania Scale, MDI Major Depression Inventory, FSDS Female Sexual Distress 
Scale, CSFQ-14 Changes of Sexual Functioning Questionnaire
Mania scale  
(ASRM)
Depression  
(MDI)
Sexual function  
(CSFQ-14)
Sexual distress  
(FSDS)
Sexual satisfaction 
(item 21)
QoL 0.22 (0.09) −0.55 (0.00) 0.24 (0.06) −0.25 (0.06) 0.33 (0.01)
Health 0.21 (0.10) −0.49 (0.00) 0.20 (0.13) −0.23 (0.07) 0.23 (0.08)
Physical health −0.05 (0.70) −0.70 (0.00) −0.04 (0.78) −0.21 (0.11) 0.21 (0.10)
Psychological health 0.03 (0.82) −0.77 (0.00) 0.16 (0.21) −0.38 (0.00) 0.36 (0.00)
Social relationships 0.08 (0.54) −0.36 (0.00) 0.40 (0.00) −0.17 (0.20) 0.76 (0.00)
Environment −0.18 (0.16) −0.39 (0.00) 0.10 (0.43) −0.13 (0.33) 0.14 (0.29)
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score was borderline associated with being sexually 
distressed [P  =  0.06, Wald  =  3.6, exp(B)  =  −0.04 (CI 
0.92–1.00)]. In further regression analyses, the WHO-
QoL subscales were added and none of these were asso-
ciated with a significant higher level of sexual distress: 
general health: P = 0.70, Wald = 0.15, exp(B) = 0.99 (CI 
0.95–1.03); psychological health: P = 0.33, Wald = 0.97, 
exp(B)  =  1.02 (CI 0.98–1.07); social relationships: 
P  =  0.95, Wald  =  0.003, exp(B)  =  1.01 (CI 0.98–1.03); 
environment: P = 0.71, Wald = 0.14, exp(B) = 0.97 (CI 
0.97–1.05), respectively.
Discussion
The present study investigated sexual dysfunction, sex-
ual distress, general sexual satisfaction and QoL in a 
cohort of women with BD and whether sexual distress 
was related to affective symptoms and QoL. Overall, 61 
women with BD were included; one-fourth had a sexual 
dysfunction (an impaired sexual function combined with 
sexual distress), more than half of the study population 
was sexually distressed and one-third was unsatisfied 
with their sexual life. Better sexual function was related 
to higher ASRM scores while sexual distress and lower 
OoL score were associated to higher MDI scores.
In comparison, an Italian study (142 patients, 60 with 
BD and 82 with unipolar depression) found a higher 
prevalence of sexual dysfunction among men and women 
with BD compared to patients with unipolar depres-
sion and healthy control persons (n  =  101) (Dell’Osso 
et  al. 2009). Another population-based Danish study 
(n  =  4415, 2295 women) found that 11% of Danish 
women had at least one sexually related problem (lubri-
cation, anorgasmia, dyspareunia and/or vaginismus) 
considered as a problem (Christensen et al. 2011a). The 
latter study did not include problems with sexual desire 
which might have underestimated the prevalence of 
sexual dysfunction since it is the most common sexually 
related problem (Hayes et al. 2006). In comparison with 
the Danish background population included as compari-
son group in the present study, the women with BD did 
not have a significantly higher prevalence of sexual dys-
function but they reported sexual distress more often. 
Anyhow, it can be difficult to compare the prevalence of 
sexual dysfunction across studies due to different defini-
tions of sexual dysfunction and varying time frames in 
questionnaires (Hayes et al. 2006; Giraldi et al. 2011).
One might have expected a higher prevalence of sex-
ual dysfunction among women with BD; however, some 
of the women in the background population might have 
been diagnosed with BD as well. We did include age 
as a potential confounder in the regression analyses. 
When compared with the entire group of women in the 
Danish background population (20–65  years) (Giraldi 
et al. 2015), the present study cohort (19–63 years) was 
younger and the prevalence of sexual dysfunction was 
more equal among age-matched control persons and 
women with BD than compared to all women in the Dan-
ish background population. It seemed that higher age did 
not predict sexual dysfunction in the background popula-
tion even though the risk of developing sexual dysfunc-
tion is higher below 30  years or above 50  years of age 
(Christensen et al. 2011a) and additionally, lower sexual 
desire is also associated with increasing age (Eplov et al. 
2007).
Sexual distress was negatively associated with sexual 
satisfaction and distress was associated with depressive 
symptom scale scores in line with other studies (Hayes 
et al. 2008). More than half of the present study popula-
tion was unsatisfied with their sexual life and it was not 
related to MDI or ASRM scores. Sanders et  al. (2011) 
found that worries about sexual life increased the risk of 
developing an impaired sexual function. This is in line 
with a study reporting that less distress was reported 
among those who were better at communicating their 
sexual needs (Hayes 2008).
Table 4 Comparison of mood symptoms and quality of life 
dividing the dividing the cohort of  women with  bipolar 
disorder according to  the Female Sexual Distress Scale 
(score <15 = not sexually distressed and score ≥15 = sex-
ual distressed)
ASRM scores defined as Altman Self-Rating Mania Scale (ASRM) score >5. 
Depression defined as Major Depression Inventory (MDI) score ≥26
SD standard deviation, BMI body mass index, WHOQoL-BREF World Health 
Organisation Quality of Life-BREF, CSFQ-14 Changes of Sexual Functioning 
Questionnaire score ≤41)
a Married, cohabiting with a partner or in a relationship but living apart
Not sexually dis-
tressed (n = 28)
Sexually distressed 
(n = 33)
P
Mean (SD)
 Age 31.9 (8.3) 33.5 (11.3) 0.54
 ASRM 3.4 (4.0) 3.9 (3.6) 0.52
 MDI 16.6 (12.2) 22.4 (11.6) 0.07
 BMI 26.8 (5.6) 26.2 (7.8) 0.77
WHOQoL-BREF
 Quality of life 3.5 (0.8) 3.1 (0.9) 0.07
 General health 3.2 (1.0) 2.8 (1.1) 0.15
 Physical health 65.1 (19.3) 60.6 (15.9) 0.33
 Psychological 
health
52.6 (19.8) 42.1 (18.8) 0.04
 Social relationships 61.4 (21.8) 56.4 (23.0) 0.39
 Environment 64.6 (14.2) 60.9 (15.0) 0.33
Number (%)
 Menopause 2 (7.1) 3 (9.1) 0.78
 In a  relationa 13 (46.4) 20 (60.6) 1.72
 Sexually active 25 (89.3) 28 (84.8) 0.90
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Quality of life (overall, general health and the four 
subscales) was associated with higher MDI scores. Bet-
ter sexual function was associated with higher scores for 
QoL overall, and for social relationships, including item 
21 also (“How satisfied are you with your sexual life?”), 
separately. Not surprisingly, those with better sexual 
function also seemed more satisfied with their sexual 
life. In comparison with the Danish background popula-
tion (a study including 568 women), the present cohort 
had lower scores on the four WHOQoL subscales (physi-
cal health: 75 ± 19 vs. 62.7 ± 17.5, psychological health: 
67 ± 17 vs. 46.9 ± 19.8, social relationships: 70 ± 18 vs. 
58.7 ±  22.4 and environment: 74 ±  16 vs. 62.6 ±  14.6) 
(Noerholm et  al. 2004). This is in line with other stud-
ies where patients with affective disorders were found to 
have lower quality of life scores (Nørholm 2008; Yatham 
et al. 2004). Sexual distress was related to a lower overall 
QoL score and for psychological health. Dichotomising 
the study population into sexually distressed and not sex-
ually distressed groups, no difference was found between 
their scores for social relationships but psychological 
health differed. This may be explained by the influence 
of psychopathology related to BD rather than social 
relationships that may have had influence on QoL in a 
negative way. The two groups did not differ according to 
age, BMI and MDI scores (although MDI scores showed 
a trend, Table  4). Those who were sexually distressed 
reported higher MDI scores which included negative 
thoughts about oneself, reduced self-esteem, problems 
with memory and concentration. It may partly contribute 
to the lower score on psychological health reported by 
the sexually distressed women with BD.
The study population had a higher BMI compared to 
the age-matched controls. The majority of women with 
BD were prescribed antipsychotics and/or mood stabi-
lisers, frequently quetiapine, lamotrigine and/or lithium 
(Table  1). Weight gain is a well-known side effect of 
antipsychotics and lithium which might have contrib-
uted to more than half of the study population being 
overweight or obese (BMI  >  25, Table  1). High BMI is 
associated with impaired sexual function and sexual 
inactivity (Christensen et al. 2011c). It is difficult to dis-
tinguish whether women who are obese (BMI ≥ 30) and 
diagnosed with BD had sexual dysfunction due to their 
psychiatric diagnosis, side effects of medication and/or 
because of their obesity or other factors. However, the 
obese participants were not prescribed more medicine 
than the rest of the cohort.
Quetiapine seems to be associated with less sexu-
ally related side effects than other antipsychotics and 
lamotrigine seems not to be related to sexual dysfunc-
tion (Serretti and Chiesa 2011a, b). In a study with only 
15 women with BD, it was estimated that around 50% 
who started treatment with lithium developed a sexual 
dysfunction (Grover et  al. 2014), while another study 
(including n = 105, 59 women with BD) concluded that 
lithium monotherapy did not present a risk factor for 
sexual dysfunction only when combined with benzo-
diazepines (Ghadirian et  al. 1992). In the present study, 
four women did take lithium in combination with ben-
zodiazepines and three of them had sexual dysfunction. 
Since they were taking more types of medication it may 
be assumed that these patients were difficult to treat and 
thereby also more clinically unstable with an impact on 
sexual function. Finally, it is well known that selective 
serotonin reuptake inhibitors (SSRI) and serotonin and 
noradrenaline reuptake inhibitors (SNRI) often have side 
effects, especially anorgasmia (Bergh and Giraldi 2014). 
However, only one of the sexually inactive women hav-
ing problems with orgasm in the present study was pre-
scribed an SSRI or SNRI but the remaining five patients 
(sexually active) taking SSRI and/or SNRI medication 
also reported problems with orgasm.
Menopause may be a risk factor for sexual dysfunc-
tion. All the post-menopausal women with BD reported 
impaired sexual function. In line with that, a Spanish 
study (n  =  260) found that menopause was associated 
with a lower score for CSFQ-14 (worse sexual function) 
(Ornat et  al. 2013) but in this study no association was 
found between a lower score of CSFQ-14 and higher age.
In the present study, more women with BD identified 
themselves as homo- or bisexual (18%, Table 1) in com-
parison with the Danish background population (1.6%) 
(Graugaard et  al. 2015). According to the latter study, 
non-heterosexual Danes reported more often that their 
sexual needs were not met, which might contribute to 
sexual distress. It is of interest that more women with 
BD identify themselves as non-heterosexual in compari-
son to the general population and that they have sexual 
distress to a higher extent. However, these questions are 
beyond the limits of the present study and need larger 
study samples to answer them.
Strengths and limitations
This study was limited by the cross-sectional design 
and a questionnaire survey does not fully explain the 
causations of sexual function, affective symptoms and 
quality of life. The study included women only and it 
is therefore recommended in future studies to include 
both sexes. However, it is the first study including sex-
ual distress in a definition of sexual dysfunction among 
women with BD. There was a high response rate (84.7%) 
which might have minimised the risk of selection bias 
towards women with BD without manic or depres-
sive symptoms—they might be more likely to answer 
the questionnaire. The study included clinical data and 
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the questionnaires were validated in order to estimate 
sexual function, sexual distress, affective symptoms 
and quality of life. Unfortunately, time frames varied 
between the questionnaires, and as it was not possible 
to change this in the present validated form, it repre-
sents a limitation.
It was a strength that age was included as a poten-
tial confounder due to the data being age- matched 
when comparing the prevalence of sexual dysfunc-
tion and distress among women with BD and Danish 
women from the background population. The present 
study was limited by not being matched according to 
sexual activity and civil status as women with BD were 
not excluded if sexually inactive (13%) or not in a cur-
rent relationship (46%). If we had excluded the sexu-
ally inactive women, the prevalence of impaired sexual 
function would have been lower. It is further a limita-
tion that the cross-sectional design of the present study 
did not allow us to explore whether they were inactive 
because of a present sexual dysfunction or whether 
they had a sexual dysfunction due to sexual inactivity 
at the time of answering the questionnaire—they might 
not have had problems with orgasm, desire or lubrica-
tion. Finally, as described, the psychopharmacological 
treatment can induce sexual dysfunction and only 7% 
of the included women were without any medication. 
Due to the low number of participants it was not possi-
ble to correlate sexual function and the different kinds 
of medication.
Conclusions
Women with BD reported a high prevalence of sexual 
distress (more than 50%) and significantly higher than 
age-matched Danish women; more than one-third were 
unsatisfied with their sexual lives. Further, sexual func-
tion seemed related to higher manic scores (positive cor-
relation) while sexual distress was negatively correlated 
with higher depressive scores. QoL scores were nega-
tively correlated with depression scores. Further, women 
reporting sexual distress had lower scores on the QoL 
subscale for psychological health, thus suggesting that 
the impact of BD influences overall QoL. Finally, the pre-
sent findings point to the fact that sexual distress can be 
an expression of depression.
However, in line with a recent review (Kopeykina et al. 
2016), although patients with BD experience disease-
specific impaired sexual functions, the existing literature 
on patients with BD sexual behaviour is mostly outdated. 
Novel research is thus needed to address sexual symp-
tomatology in BD and longitudinal studies are important 
to disentangle the causal relationship between sexual dis-
tress, affective symptoms and QoL.
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